Oncolytics Biotech Inc. (ONCY)

NASDAQ: ONCY · Real-Time Price · USD

0.5226

-0.0044 (-0.83%)

At close: Apr 2, 2025, 4:00 PM

0.5262

+0.0036 (0.68%)

After-hours: Apr 2, 2025, 7:28 PM EDT

Oncolytics Biotech Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 2, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	46	71	100	97	76	103	Upgrade
Market Cap Growth	-28.89%	-28.89%	3.47%	27.24%	-25.88%	-17.85%	Upgrade
Enterprise Value	35	58	70	73	39	82	Upgrade
PB Ratio	11.04	17.13	4.80	4.95	2.67	5.29	Upgrade
P/TBV Ratio	17.13	17.13	4.80	4.95	2.67	5.29	Upgrade
Debt / Equity Ratio	0.18	0.18	0.02	0.01	0.02	0.02	Upgrade
Quick Ratio	2.39	2.39	8.24	8.15	15.37	11.56	Upgrade
Current Ratio	2.82	2.82	9.01	9.05	16.69	12.45	Upgrade
Return on Equity (ROE)	-189.05%	-189.05%	-102.66%	-79.34%	-86.45%	-182.63%	Upgrade
Return on Assets (ROA)	-74.11%	-74.11%	-55.46%	-40.44%	-40.88%	-58.93%	Upgrade
Return on Capital (ROIC)	-124.82%	-124.82%	-76.99%	-52.89%	-52.97%	-124.54%	Upgrade
Earnings Yield	-48.03%	-30.93%	-20.98%	-18.95%	-27.32%	-17.20%	Upgrade
FCF Yield	-41.60%	-26.54%	-21.51%	-17.86%	-23.59%	-16.89%	Upgrade
Buyback Yield / Dilution	-13.10%	-13.10%	-16.53%	-8.44%	-32.66%	-82.22%	Upgrade

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q